Adverse Events Associated With Treatment for Pan-Susceptible Tuberculosis in San Francisco
- PMID: 36322073
- DOI: 10.1093/cid/ciac867
Adverse Events Associated With Treatment for Pan-Susceptible Tuberculosis in San Francisco
Abstract
Of 373 patients treated for drug-susceptible tuberculosis, 35.4% (46.2% aged ≥65 years) developed moderate/severe adverse events that required treatment interruption (34.8%), first-line drug discontinuation (26.2%, primarily pyrazinamide), second-line drug initiation (30.0%), and treatment duration up to 3.8 months longer. More safe and effective options are needed, including for the elderly.
Keywords: TB; adverse events; elderly; tuberculosis.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical